Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer

被引：0

作者：

Stiasny, Annika ^{[1
]}

Kuhn, Christina ^{[1
]}

Mayr, Doris ^{[2
]}

Alexiou, Christoph ^{[3
]}

Janko, Christina ^{[3
]}

Wiest, Irmi ^{[3
]}

Jeschke, Udo ^{[1
]}

Kost, Bernd ^{[1
]}

机构：

[1] Univ Munich, Dept Obstet & Gynecol, Campus Innenstadt,Maistr 11, D-80337 Munich, Germany

[2] Univ Munich, Dept Pathol, Munich, Germany

[3] Else Kroner Fresenius Stiftung Univ Hosp, SEON, ENT Clin, Erlangen, Germany

来源：

ANTICANCER RESEARCH | 2016年 / 36卷 / 06期

关键词：

E6; E7; HPV; cervical cancer; HUMAN-PAPILLOMAVIRUS; MESSENGER-RNA; E7; PROTEIN; P16(INK4A); INFECTION; MARKER; CELLS; HEAD; P53; DNA;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background/Aim: High-risk human papillomavirus (HPV) subtypes (i.e. 16 and 18) lead to uterine cervical cancer as well as HPV-positive oropharyngeal cancer (OSCC), a form of head and neck cancer. The induction of HPV-induced cancer is driven by virus-specific oncoproteins E6 and E7. E6 protein of HPV types 16 and 18 interacts with the E3 ubiquitin protein ligase, resulting in ubiquitination and proteolysis of tumor protein p53. E7 inactivates retinoblastoma protein (Rb) by phosphorylation followed by an increase of free eukaryotic transcription factor E2F (E2F) in the cell. This leads to an increase of cyclin-dependent kinase inhibitor p16, that is used as an immunohistochemical marker of HPV-associated OSCC. Unfortunately, p16 is not exclusively increased by E7 oncoprotein in carcinogenesis. Therefore, the aim of this study was to develop an immunohistochemical approach for the direct detection of E6/E7 oncoproteins in uterine cervical cancer as well as in OSCC. Material and Methods: Paraffin sections of uterine cervical cancer and 130 were analyzed. Immunohistochemical staining protocols were evaluated with tissue slides from patients with cervical dysplasia (CIN III) and squamous epithelial carcinoma tissue with HPV infection. Liver and placental tissues were used as negative controls. E6Specific antibody (Biorbyt) was used as primary antibody. The polymer staining method and diaminobenzidine were applied for further development. Panels of E7-specific antibodies were tested. Again, the polymer staining method and diaminobenzidine were applied for further development. Results: E6-Specific antibody revealed specific and intense staining after pre-incubation of tissue slides with citrate buffer solution. Only the E7 antibody obtained from Chemicon showed intense and specific staining in patients with CIN III and squamous epithelial carcinoma tissue. Pre-incubation with proteinase K diminished non-specific reaction. Conclusion: Our results revealed a useful staining protocol for the immunohistochemical evaluation of E6/E7 oncoprotein expression in uterine cervical cancer, as well as in HPVpositive oropharyngeal cancer. Advantages of this method compared to mRNA in situ hybridization of E6/E7 are the much lower costs, as well as the broader applicability in pathological practice.

引用

页码：3195 / 3198

页数：4

共 23 条

[1]

[Anonymous], HEAD NECK SURG

[2]

Assmann G, 2011, PATHOLOGE, V32, P391, DOI 10.1007/s00292-011-1442-2

[3] Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method [J].

Bishop, Justin A. ;

Ma, Xiao-Jun ;

Wang, Hongwei ;

Luo, Yuling ;

Illei, Peter B. ;

Begum, Shanaz ;

Taube, Janis M. ;

Koch, Wayne M. ;

Westra, William H. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) :1874-1882

[4]

Boyer SN, 1996, CANCER RES, V56, P4620

[5] ADENOVIRUS-E1A, SIMIAN VIRUS-40 TUMOR-ANTIGEN, AND HUMAN PAPILLOMAVIRUS-E7 PROTEIN SHARE THE CAPACITY TO DISRUPT THE INTERACTION BETWEEN TRANSCRIPTION FACTOR-E2F AND THE RETINOBLASTOMA GENE-PRODUCT [J].

CHELLAPPAN, S ;

KRAUS, VB ;

KROGER, B ;

MUNGER, K ;

HOWLEY, PM ;

PHELPS, WC ;

NEVINS, JR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4549-4553

[6] HPV E6/E7 RNA In Situ Hybridization Signal Patterns as Biomarkers of Three-Tier Cervical Intraepithelial Neoplasia Grade [J].

Evans, Mark F. ;

Peng, Zhihua ;

Clark, Kelli M. ;

Adamson, Christine S. -C. ;

Ma, Xiao-Jun ;

Wu, Xingyong ;

Wang, Hongwei ;

Luo, Yuling ;

Cooper, Kumarasen .

PLOS ONE, 2014, 9 (03)

[7] Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation [J].

Fehrmann, F ;

Laimins, LA .

ONCOGENE, 2003, 22 (33) :5201-5207

[8] The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1 [J].

Gupta, S ;

Takhar, PPS ;

Degenkolbe, R ;

Koh, CH ;

Zimmermann, H ;

Yang, CM ;

Sim, KG ;

Hsu, SIH ;

Bernard, HU .

VIROLOGY, 2003, 317 (01) :155-164

[9] HPV16-E6 mRNA is superior to Cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR [J].

Haefner, Norman ;

Gajda, Mieczyslaw ;

Altgassen, Christopher ;

Hertel, Hermann ;

Greinke, Christiane ;

Hillemanns, Peter ;

Schneider, Achim ;

Duerst, Matthias .

INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) :1842-1846

[10] HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - How valid is p16INK4A as surrogate marker? [J].

Hoffmann, Markus ;

Tribius, Silke ;

Quabius, Elgar Susanne ;

Henry, Hannes ;

Pfannenschmidt, Saskia ;

Burkhardt, Claudia ;

Goeroegh, Tibor ;

Halec, Gordana ;

Hoffmann, Anna Sophie ;

Kahn, Tomas ;

Roecken, Christoph ;

Haag, Jochen ;

Waterboer, Tim ;

Schmitt, Markus .

CANCER LETTERS, 2012, 323 (01) :88-96

← 1 2 3 →